ArticleBMJ open diabetes research & care2021

Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies.

Wenhuan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.